Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis

Figure 3

Kaplan-Meier curve of the time to sustained worsening on timed 25-foot walk (T25FW). Red line represents glatiramer acetate; black line represents teriflunomide. -axis is the probability of remaining free of sustained progression on T25FW, and the -axis is the days since treatment initiation.